Researchers will identify immune system genes associated with meningoencephalitis of unknown origin, a common inflammatory central nervous system disease in dog

Researchers will evaluate two types of rabies vaccines to determine any effect on the resistance to unrelated infectious and parasitic diseases, and if this effect differs between males and females.

Researchers will study the genetics of drug response variability in dogs as a first step toward developing a novel, drug sensitivity test to increase drug safety and efficacy for individual patients.

Researchers will investigate brain function, brain metabolism and gut microbiome in dogs to distinguish between epileptic seizures and an episodic movement disorder called paroxysmal dyskinesia – commonly mistaken for epileptic seizures – to improve diagnosis and appropriate treatment.

Researchers will evaluate how genetic risk factors and owner behaviors contribute to pet obesity.

Researchers will develop a test to measure blood platelets aging in dogs with a bleeding disorder called immune thrombocytopenia to inform treatment discovery.

Researchers will isolate novel antimicrobials from natural products, including plants, and test their ability to inhibit bacteria growth responsible for urinary tract infections.

Researchers will identify mosquitoes capable of transmitting heartworm disease to dogs and other mammals to inform disease management strategies.

Researchers will investigate a potential cause of red blood cell destruction in immune-mediated hemolytic anemia to inform the development of targeted treatments for this deadly autoimmune disease.